The influence of comorbid conditions on the safety profile of infliximab treatment in Japanese patients with rheumatoid arthritis: The post-marketing surveillance trial.

被引：0
|
作者：
Yano, Toshiro
Togo, Masanori
Nogami, Yoshihide
Takeuchi, Tsutomu
Koike, Takao
机构：
[1] Tanabe Seiyaku Co Ltd, Osaka, Japan
[2] Saitama Med Ctr, Dept Internal Med 2, Kawagoe, Saitama, Japan
[3] Hokkaido Univ, Grad Sch Med, Dept Med 2, Sapporo, Hokkaido, Japan
来源：
ARTHRITIS AND RHEUMATISM | 2006年 / 54卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S426 / S426
页数：1
相关论文
共 50 条
  • [21] Fluvoxamine: Safety profile in extensive post-marketing surveillance
    Buchberger, R
    Wagner, W
    PHARMACOPSYCHIATRY, 2002, 35 (03) : 101 - 108
  • [22] Tuberculosis in Japanese patients with hheumatoid arthritis treated with infliximab: Findings from the post marketing surveillance trial
    Dabbous, O.
    Gilmer, K.
    Tatsuki, Y.
    Shane, P.
    Togo, M.
    Nogami, Y.
    Tang, B.
    Thompson, H.
    Rahman, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 167 - 167
  • [23] Safety and effectiveness of abatacept in Japanese non-elderly and elderly patients with rheumatoid arthritis in an all-cases post-marketing surveillance
    Harigai, Masayoshi
    Ishiguro, Naoki
    Inokuma, Shigeko
    Mimori, Tsuneyo
    Ryu, Junnosuke
    Takei, Syuji
    Takeuchi, Tsutomu
    Tanaka, Yoshiya
    Takasaki, Yoshinari
    Yamanaka, Hisashi
    Yoshizawa, Yuri
    Chineni, Ichino
    Nakao, Toru
    Koike, Takao
    MODERN RHEUMATOLOGY, 2019, 29 (05) : 747 - 755
  • [24] Safety and effectiveness of certolizumab pegol in Japanese patients with rheumatoid arthritis: Results from a 24-week post-marketing surveillance study
    Kameda, Hideto
    Nishida, Keiichiro
    Nanki, Toshihiro
    Watanabe, Akira
    Oshima, Yukiya
    Momohara, Shigeki
    MODERN RHEUMATOLOGY, 2023, 33 (03) : 460 - 471
  • [25] Safety and effectiveness of secukinumab subcutaneous injection in Japanese patients with psoriasis vulgaris and psoriatic arthritis: A post-marketing surveillance
    Fujishige, Ayako
    Seko, Noriko
    JOURNAL OF DERMATOLOGY, 2025, 52 (01): : 11 - 23
  • [26] Shared epitope and rheumatoid arthritis severity: Association with infliximab treatment in a post-marketing study.
    Marotte, H
    Pallot-Prades, B
    Kara-Terki, R
    Tebib, J
    Gaudin, P
    Alexandre, C
    Mougin, B
    Miossec, P
    ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S536 - S536
  • [27] Effect of Golimumab Dose Escalation in Japanese Patients With Rheumatoid Arthritis: Post-Hoc Analysis of Post-Marketing Surveillance Data
    Shimizu, Hirohito
    Kobayashi, Hisanori
    Kanbori, Masayoshi
    Ishii, Yutaka
    RHEUMATOLOGY AND THERAPY, 2020, 7 (02) : 311 - 325
  • [28] Effect of Golimumab Dose Escalation in Japanese Patients With Rheumatoid Arthritis: Post-Hoc Analysis of Post-Marketing Surveillance Data
    Hirohito Shimizu
    Hisanori Kobayashi
    Masayoshi Kanbori
    Yutaka Ishii
    Rheumatology and Therapy, 2020, 7 : 311 - 325
  • [29] POST-MARKETING SURVEILLANCE OF EFFICACY AND SAFETY OF TACROLIMUS ADD-ON THERAPY IN JAPANESE RHEUMATOID ARTHRITIS PATIENTS WITHOUT AN ADEQUATE RESPONSE TO BIOLOGICAL DMARDS
    Takeuchi, T.
    Ishida, K.
    Shiraki, K.
    Yoshiyasu, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 261 - 262
  • [30] Safety of baricitinib in Japanese patients with rheumatoid arthritis: the 2020 interim report from all-case post-marketing surveillance in clinical practice
    Fujii, T.
    Atsumi, T.
    Okamoto, N.
    Takahashi, N. T. N.
    Tamura, N.
    Nakajima, A.
    Matsuno, H.
    Tsujimoto, N.
    Nishikawa, A.
    Ishii, T.
    Takeuchi, T.
    Kuwana, M.
    Takagi, M.
    Larsson, E.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2021, 50 : 25 - 25
12345